Maximum quantity allowed is 999
Please select the quantity
CAS RN: 174635-69-9 | Product Number: B6551
SB 222200

Purity: >98.0%(HPLC)
Synonyms:
- 3-Methyl-2-phenyl-N-[(1S)-1-phenylpropyl]-4-quinolinecarboxamide
- (S)-3-Methyl-2-phenyl-N-(1-phenylpropyl)quinoline-4-carboxamide
Product Documents:
Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
![]() |
---|---|---|---|---|---|
10MG |
$173.00
|
13 | ≥80 | Contact Us |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
Product Number | B6551 |
Purity / Analysis Method | >98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__2__6H__2__4N__2O = 380.49 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Air Sensitive,Heat Sensitive |
CAS RN | 174635-69-9 |
Reaxys Registry Number | 7546636 |
MDL Number | MFCD00944072 |
Specifications
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Melting point | 153.0 to 157.0 °C |
Specific rotation | -35.0 to -39.0 deg(C=0.5, methanol) |
NMR | confirm to structure |
Properties (reference)
Melting Point | 155 °C |
GHS
Related Laws:
RTECS# | VB1174632 |
Transport Information:
H.S.code* | 2933.49-000 |
Application
SB 222200: An Orally Active 2-Phenylquinoline Framework Based Neurokinin-3 (NK3) Receptor Antagonist
SB 222200 is an orally active 2-phenylquinoline framework based neurokinin-3 (NK3) receptor antagonist with high affinity, selectivity, reversibility and central nervous system penetration. It is selective for NK3 over NK1 and NK2 receptors. (The product is for research purpose only.)
References
- Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist
- Central anti-hypertensive effect of tachykinin NK3 receptor antagonists in rat
- 2-Phenyl-4-quinolinecarboxamides: A Novel Class of Potent and Selective Non-Peptide Competitive Antagonists for the Human Neurokinin-3 Receptor
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.